Source: Marketing Authorisation Holder Publisher: Oethmaan Biosims (PTY) Ltd., 207A Sherwood House, Greenacres Office Park, c/o Victory and Rustenburg Roads, Victory Park, Johannesburg 2195
Infections caused by susceptible, non-penicillinase-producing organisms including:
Upper respiratory tract infections
Skin & soft tissue infections
Lower respiratory tract infections
Gonorrhoea
Otitis media
Upper urinary tract infections
Lower urinary tract infections
Non-specific urethritis
Typhoid Fever
Gastro-intestinal tract infections
The average adult dose for ULTRAMOX is 750 mg – 1,5 g per day, but in serious infections up to 6 g daily has been administered without harmful effects.
(a) General dosages:
Adults: 250 mg (1 × 250 mg capsule) three times a day.
In severe infections these dosages may safely be increased.
(b) Specific Dosages:
Indications | Daily Dosages Adults | Children | Duration |
---|---|---|---|
Gastro intestinal tract infections | 1 – 2 g | - | 4 -5 days |
Acute typhoid Fever | 4g - | - 100 mg/kg | 14 days 21 days |
Gonorrhoea | 2 – 3 g | - | Stat |
** Gonorrhoea: Some venereologists have found tha greater dinical success has been achieved by using probenecid in conjunction with ULTRAMOX therapy.
No known symptoms of overdosage.
As with all penicillins, oral administration can cause gastro-intestinal symptoms such as transient diarrhoea, nausea and colic which are dose-related and a result of local irritation not toxicity.
Store at or below 25°C in a dry place.
KEEP OUT OF REACH OF CHILDREN.
Blisters and Patent Ready packs of 15% and 100’s and canisters containing 15 or 100 or 500 capsules.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.